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When is a health-care quality indicator ready to use?Quality indicators and how rigorous they need to be for
internal use and external reporting are debated in two inter-
esting letters in this issue. Stelfox et al. focused on quality
improvement, accountability, and research as the potential
primary goals of quality; Doggen et al. usefully expand this
to what they term external uses that include accountability,
selective referral (choosing a doctor or hospital), or increas-
ing health knowledge. Both groups agree that judgment is
needed but disagree on when an indicator is ready for use
using a framework such as that of the Institute of Medicine
(IOM). These frameworks are conceptually attractive: IOM
defines five broad criteria for good indicators: importance,
scientific soundness, feasibility, alignment, and comprehen-
siveness (safety, effectiveness, patient centeredness, timeli-
ness, efficiency, and equity). The clinical epidemiology
community should engage more actively in establishing cri-
teria for the clinical sensibility of the measures used; for
example, by developing consensus on the threshold of sci-
entific evidence for adopting quality indicators to optimize
value.
Another field which the Journal of Clinical Epidemiol-
ogy has published articles on but needs more attention in
clinical epidemiology research, is frailty [1,2]. Frailty (de-
fined as decline in physiologic reserves and resilience) is
a concept that is achieving global acceptance as an identifi-
able health state contributing to the global burden of mor-
bidity and is of increasing importance with the increased
life expectancy. One of the most widely used set of meas-
ures is the phenotypic model introduced by Fried et al. [3]
that uses five indicators of various phases of the frailty
cycle: unintentional weight loss, exhaustion, muscle weak-
ness, slow gait, and low levels of physical activity [4].
Bellinda et al. assess the trustworthiness of the results com-
paring frailty between 12 countries in Europe (Denmark,
Germany, Sweden, The Netherlands, Spain, Italy, France,
Austria, Greece, Switzerland, Belgium, and Israel) in a
Survey of Health, Ageing and Retirement in Europe
(n Z 27,938), in a population-based study of community-
dwelling adults aged O50 years between 2004 and 2006.
The authors note that a simple frailty sum score of the above
five indicators using a single question for each is useful in
the clinic, but when used across countries, it is important
to check and correct for factor invariance. For seven coun-
tries, there was no bias detected, but for the other five coun-
tries, bias was detected. Robustness and stability of these
measures are needed as a baseline and to monitor individual0895-4356  2014 Elsevier Inc.
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Open access under CC BY-NC-ND license.and community approaches to preventing and managing
frailty. This constituency of researchers in the area of
‘‘frailty’’ should link up with those working on the clinical
epidemiology challenges of ‘‘comorbidity’’ which again
means breaking out of the single disease specialty concept.
How best to report absolute results for survival curves?
Best practice in clinical epidemiology now calls for both
relative and absolute measures of treatment effect when
presenting the results of interventions. When the follow-
up is long term, median or mean comparisons should be
enriched by showing survival curves to show how early
any differences appear and whether and/or when these dif-
ferences are sustained. The default method is the Kaplane
Meier curve. To address concerns of right censoring and
evolving selection bias over time, Coory et al. make a case
with examples for the need to complement them with the
‘‘risk difference curve’’.
Should hospital inpatient mortality rates be superseded
by a ‘‘hospital-patient 1-year mortality risk score’’? van
Walraven tackles the challenge that the health services
benchmark of in-hospital mortality rates are increasingly
meaningless as we discharge patients earlier and earlier.
He suggests such an index is important not only for com-
paring health-care performance between communities or
hospitals but also for allowing patients and their physicians
to make more informed decisions about their health care
during the hospitalization and afterward. He reports here
that the risk of death within 1 year of admission to hospital
can be accurately estimated by a risk index (the hospital-
patient one-year mortality risk score) that quantifies the in-
fluence of a dozen patient and hospital factors on long-term
survival.
A field of growing importance is text messaging in clin-
ical epidemiologic research [4]. Social media is changing
the way many of us communicate with others, and as
Brabyn et al. note, it has been used already in clinical care
for appointment reminders and chronic disease manage-
ment, so it makes sense to also use this for clinical research.
This study uses short message service text messaging very
successfully (O90% response rate) in obtaining daily texts
as a tool for data collection in a trial of treatment for irrita-
ble bowel syndrome by texting a single number in answer
to a text asking for a number out of nine on the severity
of their symptoms. This immediacy has the great appeal
of obliterating recall bias in data collection but clearly is
limited by how much can be asked at one time.
962 Editorial / Journal of Clinical Epidemiology 67 (2014) 961e962Can one trust proxy measures of quality of life and well-
being for assessing the burden of illness in long-term care
institutions such as nursing homes? Devine et al. studied
this for 565 pairs of care home residents greater than
85 years of age and proxies by administering the EQ-5D
to both independently and comparing the results. The
agreement is good for those with depression and, not
surprisingly, those with lower cognitive impairment. Poor
levels of agreement were found for single domains but
achieved a minimal level of agreement for the whole index
score. This level may be acceptable for assessing burden of
illness at a macro level but is almost certainly insufficient
for assessing change at the group and/or programmatic lev-
el and certainly for assessing individual interventions.
How important is authorship order in journal publica-
tions? For clinical epidemiology researchers, this is indeed
important because it is increasingly rare to see single-
authored articles, and decisions on promotion, tenure, and
annual merit increases for individuals [and for institutional
funding] are based on journal publications as a major crite-
rion. Bhandari et al. surveyed chairpersons of departments
of medicine and surgery in North America. They confirmed
its importance, but there was considerable variation in inter-
pretation of the importance of the order itself, the corre-
sponding author role, and that of the last author. This
adds impetus to the universal adoption by all peer-review
journals of the practice of formally listing each authors con-
tributions that is advocated in a few leading journals.
Three articles address systematic review methods. Oral
medicine and dentistry systematic reviews are coming of
age so how good is their quality? Papageorgiou et al. ana-
lyzed the quality of 281 meta-analyses containing over
3,000 trials in eight databases up to 2013. Ten percent
[28 of 281] of meta-analyses were not listed in Medline,
so they recommend that other databases need searching
for this oral health topic area. We look forward to there
being criteria and data for some of the special design
features in oral health not assessed here but noted by
the authors, such as the unit of analysis (patient, mouth
quadrant, jaw, tooth, or even tooth surface), surrogate end
points, and blinding.
Is ‘‘Table 1, with the baseline comparisons’’ as important
in systematic reviews as it is in randomized controlled trial
publications? For primary data such as from randomized
trials, we all appreciate that randomization does not guaran-
tee equal allocation of known confounders so one needs to
check for baseline differences. This concept needs taking a
step further in meta-analyses: when there are small but stat-
istically nonsignificant differences in individual studies,
then if these are in the same direction overall, a substantive
difference in potential confounders can occur in systematic
reviews and meta-analyses. Clark et al. provide a nice exam-
ple of this, finding that age was imbalanced overall in five of
a sample of twelve recently published systematic reviews
with 503 component randomized trials, published in leadingjournals in 2011e2012. These authors offer four techniques
to assess this phenomenon and, if present, suggest using
these results to drive sensitivity analyses.
Howcomprehensive should searches for new studies be for
network meta-analyses (NMA) systematic reviews? NMA
systematic reviews are increasingly popular, because they
address comparative effectiveness questions of more than
one intervention even when there are no direct head-to-head
comparisons. As Lun Li et al. point out both traditional and
NMA meta-analyses need to include all available evidence
and apply a systematic and unbiased approach to estimate po-
tential differences; thus it is important to ensure the same level
of the best practice as is recommended for traditional system-
atic reviews and meta-analyses. Yet, in reviewing 248 NMAs
identified in the major search databases, the search standards
recommended in the Cochrane Handbook were not met
inO50% of these NMA publications.
Finally, an interesting article on animal research conduct
collaboration on methods between those working with
animals and with those studying humans should be encour-
aged for each side to learn from each other [5]. Bello et al.
examine the impact of not blinding outcome assessors on
estimates of intervention effects in animal experiments
modeling human clinical conditions. Although blinded out-
come assessment is recommended, it is not often employed
in practice. In 10 experimental studies involving more than
2,000 animals, each contained blinded and unblinded
assessments. There were dramatic differences between the
blinded and unblinded assessments averaging a 59% larger
effect in the unblinded studies.
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